Skip to content

Anxiety: all studies

Page 404 of 769: studies 4,031 to 4,040 of 7,689, newest first. Back to the anxiety overview

Research

The Effectiveness of a Mindfulness-Based Art Therapy Program on Sleep Quality among Urban Older Adults in Thailand: A Quasi-Experimental Study

Patient Preference and Adherence October 1, 2025 K. Makkabphalanon, Pramote Thangkratok, Chedhakitd Bunnaphasitthasothin et al.

Background Approximately 50% of older adults experience sleep disturbances. The preservation of high-quality sleep is essential; consequently, there is a pressing need for effective interventions to enhance sleep quality. Purpose This study aimed to determine the effectiveness of the Mindfulness-Based Art Therapy (MBAT) on sleep quality, depression anxiety stress, and mindful attention...

Synergistic effects of capsaicin and ketamine on the depression-like behaviors of animals subjected to the chronic unpredictable mild stress protocol.

Physiology & Behavior October 1, 2025 Irving Aguilar-Martínez, J. Góngora-Alfaro, R. Navarro-Polanco et al.

A significant percentage of depression patients are resistant to pharmacological treatments, highlighting the need for novel antidepressant strategies. Ketamine, an NMDA receptor antagonist, produces rapid antidepressant effects and is effective in treatment-resistant cases, but its association with cognitive and behavioral abnormalities resembling schizophrenia limits broader clinical utility....

The Use of Mindfulness Meditation Apps Improves Mental Health Among Graduate Students

Mindfulness October 1, 2025 Kelly A. Grogan

Abstract Objectives This study sought to determine whether mindfulness meditation training via a simple meditation app can improve well-being among graduate students. Method Graduate students were recruited from STEM programs at the University of Florida. Participants were randomly assigned into treatment and control groups. The control group continued with their typical routines during the...

Psychedelika assistierte Therapie

Psychotherapie-Wissenschaft October 1, 2025 Heiner Dörfler

Die psychedelika assistierte Psychotherapie erfährt aktuell eine wissenschaftlich fundierte Renaissance. Studien zeigen eine therapeutische Wirksamkeit von Substanzen wie Psilocybin, LSD und MDMA bei verschiedenen psychischen Störungsbildern, insbesondere bei therapieresistenter Depression, PTBS, Angstund Suchterkrankungen. In der Schweiz nimmt diese Entwicklung eine besondere Stellung ein: Als...

DOI: 10.30820/1664-9583-2025-2-7 (opens in new tab) Chronic disease Butyrophenone Continuing education Gynecology

Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders

Therapeutic Advances in Psychopharmacology October 1, 2025 Luke Flynn, Martin Krsak, Mary Rondeau et al.

Background: Job-related stress and its extreme form, burnout, continue to affect almost half of all frontline healthcare workers and first responders. Current treatments are inadequate. Objectives: To evaluate a model of ketamine-assisted psychotherapy (KAP) delivered in a group format to address symptoms of anxiety, depression, trauma, and burnout via repeated measures of the Generalized...

DOI: 10.1177/20451253251383415 (opens in new tab) Health care Stress reduction Intervention counseling Stress linguistics +7

High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review.

Annals of Internal Medicine October 1, 2025 Thanitsara Rittiphairoj, Louis Leslie, Jean-Pierre Oberste et al. 12 citations

Rapid changes in the legalized cannabis market have led to the predominance of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products. To systematically review associations of high-concentration THC cannabis products with mental health outcomes. Ovid MEDLINE through May 2025; EMBASE, Allied and Complementary Medicine Database, Cochrane Library, Database of Abstracts of Reviews...

The evidence for ketamine treatment in older adults with psychiatric illness: a scoping review

Therapeutic Advances in Chronic Disease October 1, 2025 Kayla Murphy, Julia C. Golden, Haley Schuster et al. 3 citations

Background: Ketamine, an N-methyl-D-aspartate antagonist, has been used for decades as an anesthetic agent, but more recently it has been studied in psychiatric illness. Though ketamine has been investigated for use in the general population, fewer studies have investigated the efficacy and tolerability of this treatment for older (age >60) adults. Objectives: This review sought to compile the...

“To Fathom Hell or Soar Angelic”: Theorizing a Psychedelic Politics

Theory & Event October 1, 2025 Matt Harvey

Abstract: Amidst a heyday of overlapping crises, political subjects are encouraged to pursue economic and political freedom through individual effort, amidst illusions of collectivity in digital spaces. From these logics of alienation, transhumanist solutions to these crises have gained increased traction, even striving to liberate us from the anxieties of impermanence and mortality. I note...

DOI: 10.1353/tae.2025.a971357 (opens in new tab) Impermanence Politics Illusion Soar +8

Psychedelics Reverse the Polarity of Long-Term Synaptic Plasticity in Cortical-Projecting Claustrum Neurons

eNeuro October 1, 2025 Tanner L. Anderson, Artin Asadipooya, Pavel I. Ortinski 3 citations

Psychedelic drugs have garnered increasing attention for their therapeutic potential in treating a variety of psychiatric diseases, such as depression, anxiety, and substance use disorder. The claustrum (CLA), a brain area with remarkable interconnectivity to frontal cortices, has recently been shown to have a dense population of serotonin 2 receptors (5-HT2Rs) that are activated by...

DOI: 10.1523/eneuro.0047-25.2025 (opens in new tab) Full text (opens in new tab) Neuroplasticity Excitatory postsynaptic potential Long-term potentiation Claustrum +12

Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction

Progress in Neuro-Psychopharmacology and Biological Psychiatry October 1, 2025 Marta L.c. Palhas, Rémi Corne, Raymond Mongeau 4 citations

After years of restrictions due to concerns about their potentially harmful effects, research on psychedelics has entered a new era. Increasing attention has been directed toward their immense therapeutic potential, particularly for psychiatric disorders. Pre-clinical and clinical studies have consistently demonstrated that psychedelic treatments produce therapeutic effects within hours of...